ALAMEDA, Calif.--(BUSINESS WIRE)--Scribe Therapeutics Inc. (“Scribe”), a genetic medicines company pioneering next-generation in vivo CRISPR-based medicines designed to be safe, durable, and effective ...

In front of a packed home crowd, Dabang Delhi K.C. were crowned champions of the Pro Kabaddi League (PKL) Season 12, after a thrilling 31-28 victory against Puneri Paltan at the Thyagaraj Indoor ...

Vishwas S led from the front as Bengal Warriorz kept their playoff hopes alive with a thrilling 44-43 win over Tamil Thalaivas in the Pro Kabaddi League on Tuesday. Vishwas shone with 19 points, while ...

The game between Colombia & Ecuador resulted in 1-0 win for Colombia during the 2021 Copa America league stages. The solo goal of the match came during the end of the first half of the match.

One of the top companies in the smartphone market, Vivo, is getting ready to launch a new, potent model in India under its well-liked T-series. The Vivo T4 Pro, a forthcoming gadget, has already been ...

Get a look at the Jets on the field during the second week of OTA practices under the direction of head coach Aaron Glenn and general manager Darren Mougey. Get a look at the Jets on the field during ...

DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing ...

ALAMEDA, Calif.--(BUSINESS WIRE)-- Scribe Therapeutics Inc. (Scribe), a genetic medicines company unlocking the potential of CRISPR to transform human health, today announced its participation in the ...

Mr. Van Hollen speaking to the news media on Thursday. “My argument here all along in this is that he just requires due process,” he said of Mr. Abrego Garcia this week.Credit...Daniele Volpe for The ...

Vivo, China's top smartphone brand from 2021 to 2024, is making a surprising pivot into the home robotics market. While global tech giants double down on electric vehicles (EVs) amid a saturated ...

Tessera Therapeutics Highlights Advances Across In Vivo Programs for Sickle Cell Disease and T-Cell Therapies at the 66th American Society of Hematology Annual Meeting Provided by GlobeNewswire Dec 9, ...